103
Views
6
CrossRef citations to date
0
Altmetric
Review

Prediction and prevention of stroke after transient ischemic attack in the short and long term

&
Pages 381-395 | Published online: 10 Jan 2014

References

  • Bosanquet N, Franks P. Stroke Care: Reducing the Burden of Disease. The Stroke Association, London, UK (1998).
  • Menken M, Munsat TL, Toole JF. The global burden of disease study. Implications for neurology. Arch. Neurol. 57, 418–420 (2000).
  • Rothwell PM. Incidence, risk factors and prognosis of stroke and transient ischaemic attack: the need for high-quality large-scale epidemiological studies. Cerebrovas. Dis. 16(Suppl. 3), 2–10 (2003).
  • Rothwell PM, Warlow CP. Timing of transient ischaemic attacks preceding ischaemic stroke. Neurology 64, 817–820 (2005).
  • The Intercollegiate WorkingParty for Stroke. National Clinical Guidelines for Stroke. London, UK (2004).
  • Wolf PA, Clagett GP, Easton JD et al. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 30, 1991–1994 (1999).
  • Johnston SC, Smith WS. Practice variability in management of transient ischemic attacks. Eur. Neurol. 42, 105–108 (1999).
  • Giles MF, Rothwell PM. The need for emergency treatment of transient ischemic attack and minor Stroke. Expert Rev. Neurotherapeutics 5(2), 203–210 (2005).
  • Whisnant JP, Matsumoto N, Elveback LR. Transient cerebral ischemic attacks in a community. Rochester, Minnesota, 1955 through 1969. Mayo. Clin. Proc. 48, 194–198 (1973).
  • Hankey GJ, Warlow CP. Transient ischaemic attacks of the brain and eye. Vol 27. In: Major Problems in Neurology Series. WB Saunders Company, London, UK (1994).
  • Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 284, 2901–2906 (2000).
  • Hill MD, Yiannakoulias N, Jeerakathil T, Tu JV, Svenson LW, Schopflocher DP. The high risk of stroke immediately after transient ischemic attack. A population-based study. Neurology 62, 2015–2020 (2004).
  • Gladstone DJ, Kapral MK, Fang J, Laupacis A, Tu JV. Management and outcomes of transient ischaemic attacks in Ontario. Canadian Med. Ass. J. 1707, 1099–1104 (2004).
  • Lovett J, Dennis M, Sandercock PAG, Bamford J, Warlow CP, Rothwell PM. The very early risk of stroke following a TIA. Stroke 34, E138–E140 (2003).
  • Coull A, Lovett JK, Rothwell PM, on behalf of the Oxford Vascular Study. Early risk of stroke after a TIA or minor stroke in a population-based incidence study. Br. Med. J. 328, 326–328 (2004).
  • Kernan WN, Feinstein AR, Brass LM. A methodological appraisal of research on prognosis after transient ischemic attacks. Stroke 22, 1108–1116 (1991).
  • Terent A. Survival after stroke and transient ischemic attacks during the 1970’s and 1980’s. Stroke 21, 848–853 (1990).
  • Ricci S, Cantisani AT, Righetti E, Duca E, Spizzichino L. Long term follow-up of TIA’s: the SEPIVAC Study. Neuroepidemiology 17, 54 (1998).
  • Dennis M, Bamford J, Sandercock P, Warlow C. Prognosis of transient ischaemic attacks in the Oxfordshire Community Stroke Project. Stroke 21, 1320–1326 (1990).
  • Hankey GJ. Long term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc. Dis. 16(Suppl. 1), 14–19 (2003).
  • Hankey GJ, Slattery JM, Warlow CP. The prognosis of hospital-referred transient ischaemic attacks. J. Neurol. Neurosurg. Psychiatry 54, 793–802 (1991).
  • Clark TG, Murphy MFG, Rothwell PM. Long term risks of stroke, myocardial infarction, and vascular death in “low risk” patients with a non-recent transient ischaemic attack. J. Neurol. Neurosurg. Psychiatry 74, 577–580 (2003).
  • Van Wijk I, Kappelle LJ, van Gijn J et al. for the LILAC study group. Long-term survival and vascular event risk after transient ischaemic attack or minor stroke: a cohort study. Lancet 365, 2098–2104 (2005).
  • Dennis MS, Bamford JM, Sandercock PA, Warlow CP. Incidence of transient ischemic attacks in Oxfordshire, England. Stroke 20, 333–339 (1989).
  • Rothwell PM, Giles MF, Flossmann E et al. A simple score (ABCD) to identify individuals at high early risk of stroke after a transient ischaemic attack. Lancet 366, 29–36 (2005).
  • The National Instituteof Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic Stroke. N. Engl. J. Med. 333, 1581–1587 (1995).
  • Johnston SC, Easton JD. Are patients with acutely recovered cerebral ischemia more unstable? Stroke 34, 2446–2450 (2003).
  • Albers GW, Caplan LR, Easton JD et al. The TIA Working Group. Transient ischemic attack–proposal for a new definition. N. Engl. J. Med. 347, 1713–1716 (2002).
  • Flossman E, Rothwell PM. Prognosis of vertebrobasilar TIA and minor ischaemic stroke. Brain 126, 1940–1954 (2003).
  • Benavente O, Eliasziw M, Streifler JY, Fox AJ, Barnett HJ, Meldrum H, for the NASCET Collaborators. Prognosis after transient monocular blindness associated with carotid artery stenosis. N. Engl. J. Med. 345, 1084–1090 (2001).
  • Hankey GJ, Slattery JM, Warlow CP. Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events? J. Neurol. Neurosurg. Psychiatry 55, 640–652 (1992).
  • Lovett JK, Coull A, Rothwell PM, on behalf of the Oxford Vascular Study. Early risk of recurrent stroke by aetiological subtype: implications for stroke prevention. Neurology 62, 569–574 (2004).
  • Adams HP Jr, Bendixen BH, Kappelle LJ et al. Classification of sub-type of acute ischaemic stroke definitions for use in multicenter clinical trials. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24, 35–41 (1993).
  • Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoefer B, Heuschmann PU. Epidemiology of ischemic stroke of subtypes according to TOAST criteria: incidence, recurrence and long term survival in ischemic stroke subtypes: a population based study. Stroke 32, 2735–2740 (2001).
  • Petty GW, Brown R-DJ, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO. Ischaemic stroke subtypes: a population based study of functional outcome, survival and recurrence. Stroke 31, 1062–1068 (2000).
  • Rothwell PM, Coull A, Giles MF et al. The Oxford Vascular Study. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 363, 1925–1933 (2004).
  • Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project-1981–86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry. 53, 16–22 (1990).
  • Armstrong PW, Fu Y, ChangW-C et al., for the GUSTO-IIb investigators. Acute coronary syndromes in GUSTO-IIb trial: prognostic insights and impact of recurrent ischaemia. Circulation 98, 1860–1868 (1998).
  • van Swieten JC, Kappelle LJ, Algra A, van Latum JC, Koudstaal PJ, van Gijn J. Hypodensity of cerebral white matter in patients with transient ischaemic attack or minor stroke: influence on the rate of subsequent stroke: Dutch TIA Study Group. Ann. Neurol. 32, 177–183 (1992).
  • Evans GW, Howard G, Murros KE, Rose LA, Toole JF. Cerebral infarction verified by cranial computed tomography and prognosis for survival following transient ischemic attack. Stroke 22, 431–436 (1991).
  • The Dutch TIA TrialStudy Group. Predictors of major vascular events in patients with a transient ischemic attack or nondisabling stroke: the Dutch TIA Trial Study Group. Stroke 24, 527–531 (1993).
  • Davalos A, Matias-Guiu J, Torrent O, Vilaseca J, Codina A. Computed tomography in reversible ischaemic attacks: clinical and prognostic correlations in a prospective study. J. Neurol. 235, 155–158 (1988).
  • Dennis M, Bamford J, Sandercock P, Molyneux A, Warlow C. Computed tomography in patients with transient ischaemic attacks: when is a transient ischaemic attack not a transient ischaemic attack but a stroke? J. Neurol. 237, 257–261 (1990).
  • Douglas CD, Johnston CM, Elkins J, Sidney S, Gress DR, Johnston SC. Head computed tomography findings predict short-term stroke risk after transient ischemic attack. Stroke 34, 2894–2899 (2003).
  • Purroy F, Montaner J, Rovira A, Delgado P, Quintana M, Alvarez-Sabin J. Higher risk of further vascular events among transient ischaemic attack patients with diffusion-weighted imaging acute lesions. Stroke 35, 2313–2319 (2004).
  • Coutts SB, Simon JE, Eliasziw M et al. Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann. Neurol. 57, 848–854 (2005).
  • Valton L, Larrue V, le Traon AP, Massabuau P, Geraud G. Microembolic signals and risk of early recurrence in patients with stroke or transient ischemic attack. Stroke 29, 2125–2128 (1998).
  • Molloy J, Markus HS. Asymptomatic embolization predicts stroke and TIA risk in patients with carotid artery stenosis. Stroke 30, 1440–1443 (1999).
  • Howard G, Toole JF, Frye-Pierson J, Hinshelwood LC. Factors influencing the survival of 451 transient ischemic attack patients. Stroke 18, 552–557 (1987).
  • Kernan WN, Viscoli CM, Brass LM et al. The Stroke Prognosis Instrument II (SPI II): a clinical prediction instrument for patients with transient ischaemia and non-disabling ischaemic stroke. Stroke 31, 456–462 (2000).
  • European Carotid SurgeryTrialists’ Collaborative Group. MRC European Carotid Surgery Trial. Interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet 337, 1235–1243 (1991).
  • Rothwell PM, Warlow CP, on behalf of the ECST Collaborators. Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. Lancet 353, 2105–2110 (1999).
  • Rothwell PM, Mehta Z, Howard SC, Gutnikov SA, Warlow CP. From subgroups to individuals: general principles and the example of carotid endartectomy. Lancet 365, 256–265 (2005).
  • North American SymptomaticCarotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N. Engl. J. Med. 325, 445–453 (1991).
  • Rothwell PM, Eliasziw M, Gutnikov SA et al. Carotid Endarterectomy Trialists’ Collaboration. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 361, 107–116 (2003).
  • Atrial FibrillationInvestigators. Risk factors for stroke and efficacy of anti-thrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch. Intern. Med. 154, 1449–1457 (1994).
  • Stroke Prevention inAtrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, I: clinical features of patients at risk. Ann. Intern. Med. 116, 1–5 (1992).
  • Stroke Prevention inAtrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, II: echocardiographic features of patients at risk. Ann. Intern. Med. 116, 6–12 (1992).
  • van Latum JC, Koudstaal P, Venables GS, van Gijn J, Kappelle LJ, Algra A. Predictors of major vascular events in patients with a transient ischemic attack or minor ischemic stroke and with nonrheumatic atrial fibrillation. Stroke 26(5), 801–806 (1995).
  • Ariesen MJ, Algra A, Warlow CP, Rothwell PM. Prognostic factors of primary intracerebral hemorrhage risk in patients after an episode of cerebral ischemia. J. Neurol. Neurosurg. Pschy. 77(1), 92–94 (2005).
  • The Stroke Preventionin Reversible Ischemia Trial (SPIRIT) Study Group. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann. Neurol. 42(6), 857–865 (1997).
  • Nighoghossian N, Hermier M, Adeleine P et al. Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study. Stroke 33, 735–742 (2002).
  • Kidwell CS, Saver JL, Carneado J et al. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke 33, 717–724 (2002).
  • Warlow CP, Dennis MS, van Gijn J, Sandercock PAG, Bamford JM, Wardlaw JM. Preventing recurrent stroke and other serious vascular events. In: Stroke: A Practical Guide to Management. Blackwell Science Ltd, Oxford, UK (2001).
  • Weir NU, Demchuk AM, Buchan AM, Hill MD. Stroke prevention. MATCHing therapy to the patient with TIA. Postgrad. Med. 117, 26–30 (2005).
  • Albers GW. A review of published TIA treatment recommendations. Neurology 62(Suppl. 6), 26–28 (2004).
  • International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both or neither among 19435 patients with acute ischaemic Stroke. Lancet 349, 1569–1581 (1977).
  • CAST (Chinese AcuteStroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic. Stroke. Lancet 349, 1641–1649 (1997).
  • Diener HC, Bogousslavsky J, Brass LM et al. On behalf of the MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high-risk patients (MATCH): randomised double-blind, placebo-controlled trial. Lancet 364, 331–337 (2004).
  • Markus HS, Droste DW, Kaps M et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 111, 2233–2240 (2005).
  • Schwartz GG, Olsson AG, Ezekowitz MD et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: a randomized controlled trial. JAMA 285, 1711–1718 (2001).
  • Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJM, for the Carotid Endarterectomy Trialists’ Collaboration. Effect of endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and the timing of surgery. Lancet 363, 915–924 (2004).
  • Bond R, Rerkasem K, Rothwell PM. A systematic review of the risks of carotid endarterectomy in relation to the clinical indication and the timing of surgery. Stroke 34, 2290–2301 (2003).
  • COSSACS Trial Group. COSSACS (Continue or Stop post-Stroke Antihypertensives Collaborative Study): rationale and design. J. Hypertens. 23(2), 455–458 (2005).
  • PROGRESS CollaborativeGroup. Randomised trial of a perindopril-based blood-presure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358, 1033–1041 (2001).
  • Rothwell PM, Howard SC, Spence JD. Carotid Endarterectomy Trialists’ Collaboration. Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke 34, 2583–2590 (2003).
  • Kennedy J, Eliasziw M, Hill MD, Buchan AM. The Fast Assessment of Stroke and Transient Ischemic Attack to prevent Early Recurrence (FASTER) Trial. Semin. Cerebrovas. Dis. Stroke 3, 25–30 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.